Acting as a triple agonist for glucagon, GLP-1, and GIP receptors, this drug has been able to ramp up energy use and promote weight loss comparable to bariatric surgery
Future Developments Researchers are also exploring whether different formulations may improve patient experience and adherence, including: Prefilled injection pens (single- or multi-use) Potential oral formulations (though none are yet in advanced trials) Combination therapies pairing Retatrutide with other metabolic agents Emerging Retatrutide Dosing Strategies As research progresses and Phase III trials expand, clinicians and researchers are exploring alternative titration strategies that may improve tolerability and optimize metabolic outcomes
Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) have shown to improve efficacy compared to older weight-loss medications, with patients losing up to 20% of their body weight
Vitamin B12 helps reduce the gastrointestinal side effects commonly associated with initiating GLP-1/GIP therapy, including nausea
When compared to the prices of our favorite greens powders, only AG1 is more expensive than Grns
Should You Microdose GLP-1 Drugs